Showcases Stock ranks

Aslan Pharmaceuticals Ltd ADR (ASLN)
1.67  0.04 (2.45%) 08-05 16:00
Open: 1.63 Pre. Close: 1.63
High: 1.6734 Low: 1.61
Volume: 30,633 Market Cap: 32M
ASLAN Pharmaceuticals Limited operates as a clinical-stage oncology and inflammatory disease focused biopharmaceutical company in the United States. It targets diseases that are prevalent in Asia, and orphan indications in the United States and Europe. The company's lead program, varlitinib, is a reversible small molecule pan-human epidermal growth factor receptor (HER), inhibitor that targets the human epidermal growth factor receptors HER1, and HER2, as well as gastric cancer. Its Varlitinib completed a pivotal clinical trial for biliary tract cancer. In addition, the company is developing ASLAN003, an orally active potent inhibitor of human dihydroorotate dehydrogenase that is in Phase II clinical trials to treat acute myeloid leukemia; and ASLAN004, an interleukin 4/interleukin 13 receptor antibody for the treatment of severe atopic dermatitis and asthma.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 1.673 - 1.679 1.679 - 1.686
Low: 1.594 - 1.601 1.601 - 1.608
Close: 1.658 - 1.671 1.671 - 1.683
Stock Technical Analysis
Target: Six months: 2.18
One year: 2.44
Support: Support1: 1.51
Support2: 1.26
Resistance: Resistance1: 1.87
Resistance2: 2.09
Pivot: 1.74
Moving Averages: MA(5): 1.60
MA(20): 1.76
MA(100): 1.64
MA(250): 1.82
MACD: MACD(12,26): -0.07
Signal(12,26,9): -0.06
%K %D: %K(14,3): 20.69
%D(3): 12.48
RSI: RSI(14): 43.94
52-Week: High: 8.18
Low: 0.35
Change(%): -45.2
Average Vol(K): 3-Month: 11383
10-Days: 9205
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.

ASLN has closed above bottom band by 37.2%. Bollinger Bands are 1.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Wed, 05 Aug 2020
Asian ADRs Climb Higher in Wednesday Trading - InvestorsObserver

Tue, 28 Jul 2020
Asian ADRs Move Sharply Lower in Tuesday Trading - InvestorsObserver

Fri, 24 Jul 2020
Asian ADRs Move Higher in Friday Trading - InvestorsObserver

Fri, 17 Jul 2020
The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient - Benzinga

Thu, 16 Jul 2020
Asian ADRs Move Lower in Thursday Trading - InvestorsObserver

Mon, 04 May 2020
ASLAN PHARMACEU/ADR Should you short it before the Earnings result? : (NASDAQ:ASLN) - Stock Market Daily

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37.99
Shares Float (M) 36.90
% Held by Insiders
% Held by Institutions 8.68
Shares Short (K) 28
Shares Short Prior Month (K) 11
Stock Financials
EPS -1.240
Book Value (p.s.) -0.230
Profit Margin
Operating Margin
Return on Assets (ttm) -41.6
Return on Equity (ttm) -769.8
Qtrly Rev. Growth
Gross Profit (p.s.) 2.101
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
PE Ratio -1.35
PEG Ratio
Price to Book value -7.26
Price to Sales
Price to Cash Flow
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator